McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
109.66B
Market cap109.66B
Price-Earnings ratio
21.56
Price-Earnings ratio21.56
Dividend yield
0.40%
Dividend yield0.40%
Average volume
1.19M
Average volume1.19M
High today
$901.11
High today$901.11
Low today
$880.77
Low today$880.77
Open price
$881.27
Open price$881.27
Volume
189.05K
Volume189.05K
52 Week high
$999.00
52 Week high$999.00
52 Week low
$637.00
52 Week low$637.00

Stock Snapshot

With a market cap of 109.66B, McKesson(MCK) trades at $894.66. The stock has a price-to-earnings ratio of 21.56 and currently yields dividends of 0.40%.

During the trading session on 2026-08-11, McKesson(MCK) shares reached a daily high of $901.11 and a low of $880.77. At a current price of $894.66, the stock is +1.6% higher than the low and still -0.7% under the high.

Trading volume for McKesson(MCK) stock has reached 189.05K, versus its average volume of 1.19M.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

MCK News

TipRanks 5h
McKesson price target raised to $933 from $812 at Wells Fargo

Wells Fargo raised the firm’s price target on McKesson (MCK) to $933 from $812 and keeps an Equal Weight rating on the shares. The firm is increasing estimates...

Simply Wall St 4d
McKesson Stock Pauses Despite Higher Guidance And EPS Strength

McKesson stock barely flinched after earnings, slipping about 1% from its recent highs, even though the company just posted the kind of pharmaceutical distribut...

McKesson Stock Pauses Despite Higher Guidance And EPS Strength
Simply Wall St 6d
Is McKesson’s Revenue Growth With Falling EPS Altering The Investment Case For McKesson?

McKesson Corporation has reported past first-quarter 2026 results, with sales rising to US$105.38 billion from US$97.83 billion a year earlier, while net income...

Is McKesson’s Revenue Growth With Falling EPS Altering The Investment Case For McKesson?

Analyst ratings

86%

of 21 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More MCK News

Barron's 6d
Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Healthcare Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy. In this article XLV LLY VRTX GILD MCK Many healthcare and pharmaceutic...

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.